Biotechnology Analyst Boris Peaker Joins Cowen’s Equity Research Department
Peaker
Managing Director to cover Biotechnology stocks. Mr. Peaker is based in
“We’re thrilled to welcome Boris back to Cowen, where he began his
equity research career,” said Mr. Fagin. “We look forward to adding
Boris’ insightful research product to our already preeminent biotech
platform, and to his collaboration with the rest of our health care
team.”
Mr. Peaker joins Cowen from
years as a senior research analyst covering the biotechnology sector. He
previously held biotechnology equity research positions at Rodman &
Renshaw and at
degrees in Physics and in Chemistry, summa cum laude, from
University of New York
About
with its consolidated subsidiaries, provides alternative asset
management, investment banking, research, and sales and trading services
through its two business segments: Ramius and its affiliates make up the
Company’s alternative investment segment, while
its affiliates make up the Company’s broker-dealer segment. Ramius
provides alternative asset management solutions to a global client base
and manages a significant portion of Cowen’s proprietary capital.
and Company
for growth-oriented companies, domain knowledge-driven research and a
sales and trading platform for institutional investors. Founded in 1918,
the firm is headquartered in
Source:
Media:
Sard Verbinnen & Co
Dan Gagnier/Carissa
Felger
212-687-8080